- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about XBI
Recent news which mentions XBI
From MarketWatch
2 Biotech Stocks That Could Be 10-Baggers in 2022
January 26, 2022
From Motley Fool
As stock-market turbulence revs up, this ETF theme has drawn 32% of flows in 2022 so far: ‘This isn’t a flash in the pan’
January 20, 2022
From MarketWatch
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
From InvestorPlace
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations
January 03, 2022
From Benzinga
These are the best ETFs and themes to buy in 2022, and its all about yields, says Astoria Advisors
December 30, 2021
From MarketWatch
10 Bargain Stocks to Buy After Falling 30% in 2021
December 20, 2021
From InvestorPlace
3 Last-Minute Healthcare Stocking Stuffers
December 18, 2021
From Motley Fool
Forget crypto! Some ETF providers bet that this $800 billion industry in 2024 is fund investing’s new frontier
December 09, 2021
From MarketWatch
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
From Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
From Motley Fool
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
From Motley Fool
From MarketWatch
2 Falling-Knife Stocks Actually Worth Buying Right Now
November 18, 2021
From Motley Fool
The anti-Cathie Wood ETF has landed. Here’s how it’s doing so far
November 11, 2021
From MarketWatch
2 Biotech Stocks Set to Go Supernova Soon
October 18, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
From Motley Fool
15 Charts All Traders Should Look At Every Morning
September 30, 2021
From Benzinga
2 Best Biotech Stocks to Buy Right Now
September 25, 2021
From Motley Fool
Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years
September 23, 2021
From Motley Fool
A $2.5 trillion behemoth among mutual funds wants in on ETFs — underscoring a fast-moving trend
August 26, 2021
From MarketWatch
3 Stocks to Buy for the Second Half of 2021
August 09, 2021
From InvestorPlace
Carter Worth And Mike Khouw's XBI Trade
August 08, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.